LakeShore Biopharma's total assets for Q3 2024 were ¥1.51B, a decrease of -6.24% from the previous quarter. LSB total liabilities were ¥1.01B for the fiscal quarter, a -3.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.